Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area
NCT00702104 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2013-05-14
Summary
RATIONALE: Screening may help doctors find prostate cancer sooner, when it may be easier to treat.
PURPOSE: This research study is looking at whether patients who are being screened for prostate cancer have been previously screened.
Conditions
Interventions
- OTHER
-
survey administration
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Mack Roach, MD · University of California, San Francisco
Eligibility
- Min Age
- 35 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Primary Completion
- 2008-01-31
Countries
- United States
Study Locations
More Related Trials
-
Randomized Trial of Trust in Online Videos About Prostate Cancer
NCT05886751 ·Status: COMPLETED ·Phase: NA
-
Facilitating Participation in a Prostate Cancer Risk Assessment Program
NCT02126319 ·Status: COMPLETED ·Phase: NA
-
Protein Kinase A in Prostate Cancer Tissue.
NCT05460312 ·Status: UNKNOWN
-
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
NCT00898274 ·Status: COMPLETED
-
Markers for Early Detection of Prostate Cancer
NCT00340717 ·Status: COMPLETED
-
Men at High Genetic Risk for Prostate Cancer
NCT03805919 ·Status: RECRUITING
-
Prostate Cancer Genetic Risk Evaluation and Screening Study
NCT05129605 ·Status: RECRUITING
-
Understanding of Genetics by Men at Risk for Prostate Cancer
NCT04550845 ·Status: RECRUITING ·Phase: NA
-
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 ·Status: COMPLETED
-
Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors
NCT03459755 ·Status: WITHDRAWN ·Phase: NA
-
A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)
NCT03423303 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men
NCT00761124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies
NCT04541030 ·Status: ACTIVE_NOT_RECRUITING
-
Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer
NCT00045331 ·Status: COMPLETED ·Phase: NA
-
Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer
NCT00769223 ·Status: ACTIVE_NOT_RECRUITING
-
Men's Prostate Awareness Church Training
NCT02131779 ·Status: COMPLETED ·Phase: NA
-
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer
NCT01013129 ·Status: COMPLETED
-
Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result
NCT01024959 ·Status: COMPLETED ·Phase: NA
-
Smart Prostate Specific Antigen (PSA) Screening Study
NCT04782713 ·Status: COMPLETED ·Phase: NA
-
MRI Screening in Men at High Risk of Developing Prostate Cancer
NCT05608694 ·Status: RECRUITING ·Phase: NA
-
Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL
NCT04317625 ·Status: UNKNOWN ·Phase: NA
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
NCT05295407 ·Status: RECRUITING
-
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy
NCT00850941 ·Status: UNKNOWN
-
Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy
NCT00373035 ·Status: COMPLETED
-
Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors
NCT02957357 ·Status: COMPLETED